HEPION PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $1.3M | $7.4M |
| FY2017 | — | $9.1M | $13.0M |
| FY2018 | — | $1.7M | $2.8M |
| FY2019 | — | $15.6M | $13.9M |
| FY2020 | — | $40.5M | $40.7M |
| FY2021 | — | $117.6M | $91.3M |
| FY2022 | — | $49.9M | $51.2M |
| FY2023 | — | $7.3M | $14.8M |
| FY2024 | — | $-1.9M | $406.4K |
| FY2025 | — | $2.7M | $1.8M |